№6 (supplement) / 2016

Russian clinical guidelines
D.Yu. Pushkar', A.D. Kaprin, B.Ya. Alekseev, E.A. Bezrukov, A.V. Govorov, K.B Kolontarev, G.E. Krupinov, N.V. Vorob'ev, A.A. Krasheninnikov
Prostate Cancer 		4-33
A.D. Kaprin, A.A. Kostin, B.Ya. Alekseev, K.M. Nyushko, N.V. Vorob'ev, A.S. Kalpinskii
Renal Cancer 		34-63
A.D. Kaprin, A.A. Kostin, L.M. Rapoport, D.G. Tsarichenko, A.N. Bernikov, N.V. Vorob'ev, M.P. Golovashchenko
Cancer of Urinary Bladder 		64-88
A.V. Govorov, S.V. Smirnova, N.V. Vorob'ev, P.V. Shegai
Penile Cancer 		89-99
A.A. Kostin, B.Ya. Alekseev, N.V. Vorob'ev, P.V. Shegai, K.B. Kolontarev
Testicular and Paratesticular Tumours 		100-109
Leading experts’ view on the problem
A.V. Govorov, A.O. Vasil'ev, D.Yu. Pushkar
Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature 		110-114

Бионика Медиа